Since the past 40 years, the number of technology innovations both within and around medical devices have increased dramatically. Especially, the past 20 years have witnessed an acceleration in the sector, thanks to the Internet of Things and rise of its other corresponding parts like wireless connectivity, cloud computing, and AI, etc. These advancements have transformed the healthcare processes.
Even after 20 years, these leading-edge technologies are continuing to source a seismic shift in the process of healthcare administration and delivery.
And now, mobile applications have also seeped in and have become an important part of these highly demanded, technology-based medical and non-medical purposes.
These Apps or Software which are a medical device on their own – Software as a Medical Device – have grown to become an inherent part of the users’ life. The application of SaMD are not just limited to diagnosis but have also made their place in the monitoring and treatment process.
Seeing the growing inclusion of SaMD in the everyday healthcare, The International Medical Device Regulators Forum have described the concept and SaMD risk categories in detail for the medical app development industry to follow.
* SaMD is not the only compliance that healthcare industry stakeholders – mHealth applications entrepreneurs and device manufacturers should follow. There are other compliances as well, such as FDA, HIPAA, HL7, and FCPA. We have touched upon these compliances in much detail in our mHealthcare App Development Guide.
In this article, we are going to throw some light on what is SaMD, the regulations that it entails, and what mHealth app types which are categorized as Software as a Medical Device.
The terminology – Software as a Medical Device stands for any software that is intended for use for one or multiple medical purposes and which performs these purposes without being integrated into a hardware medical device.
‘The term “Software as a Medical Device” (SaMD) is defined as software intended to be used for one or more medical purposes that perform these purposes without being part of a hardware medical device.’
There are two ways through which SaMDs are characterized:
On the basis of these characterizations, SaMDs are divided into four categories.
[table id=35 /]
SaMD companies should have a good Quality Management System incorporated into the development process to ensure compliance with any regulation. The chosen QMS platform should be capable of compliance with regulatory requirements like the FDA 21 CFR Part 820 and ISO 13485:2016.
Any misstep in the direction can lead to severe consequences with your application getting banned being only the tipping point. Noting the cruciality, it is advised that you should partner with a knowledgeable mHealth app development company who works alongside medical practitioners who understand these regulations and compliances to their entirety.
The app examples are not limited to these. There are a number of other app types which do not fall under the definition of SaMDs.
SaMD applications are those which act as a stand-alone health application that gives users the insight into their physical health by making diagnosis, doing X-ray processing, or calculating insulin doses.
Q. What is IEC 62304?
IEC 62304 is a standard that specifies the life cycle requirements needed for the creation of Software as a Medical Device and Software within medical devices. When used along with ISO 13485, it offers a framework that is important for safe designing and maintenance of medical device software.
We have our own internal QMS for working with medical device and pharmaceutical clients, to ensure our own quality. We do not get audited by clients, third parties, or regulators.
Stage 1 : Initiate Project: Conduct a kick-off teleconference with Client to:
Review the project plan and timeline
Finalize key sources of information
Define the project team
Stage 2 : Review Documentation: Evaluate and examine all relevant documents including existing product information, nonclinical data/plans, and regulatory documentation. The sources of this information are:
Non-clinical data, regulatory correspondence, product technical specifications, references to predicate devices, proposed product claims and intended/indications for use, etc.
Stage 3: Determine Regulatory Pathway Using information from above section, Develop an FDA regulatory path determining whether 510(k) or de novo is most appropriate (a PMA regulatory strategy is more complex and will require a higher budget). The goal will be to advise Client on the optimal approach to FDA.
Sudeep Srivastav, the CEO of Appinventiv, is someone who has established himself as the perfect blend of optimism and calculated risks, a trait that has embossed itself in every work process of Appinventiv. Having built a brand that is known to tap the unexplored ideas in the mobile industry, he spends his time exploring ways to take Appinventiv to the point where technology blends with lives.
B-25, Sector 58,
Noida- 201301,
Delhi - NCR, India
Suite 3810, Bankers Hall West,
888 - 3rd Street Sw
Calgary Alberta